Search General Info
Search Education
Search Partnering Companies

Federico Goodsaid

San Juan, Puerto Rico, United States
Federico Goodsaid, PhD (, Chief Executive Officer of MBQ Pharma is also Principal Consultant at Regulatory Pathfinders LLC, a regulatory consulting practice focused on regulatory strategy and pathways required for precision medicine therapeutic and diagnostic products. Prior to this appointment, he was the Senior Vice President for Product Development and Regulatory Affairs at TOMA Biosciences, where he worked on the preclinical and clinical development and regulatory submissions for a 130-gene targeted NGS oncology panel. His previous work at Vertex focused on therapeutic product submissions in cystic fibrosis which led to the first in-vitro surrogate label expansion for Kalydeco. He was previously Associate Director for Operations in Genomics and Biomarker Qualification Coordinator at the Office of Clinical Pharmacology/Office of Translational Sciences/ Center for Drug Evaluation and Research/ U.S. FDA.
Speaking In
[On Demand]
MBQ Pharma is an oncotherapy company, developing Rac and CDC42 inhibitors as tumor growth…